USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ACCESS PHARMACEUTICALS, INC.
Address:
2600 Stemmons Freeway, Suite 176
Dallas, TX 75207 0210
Phone:
(214) 905-5100
URL:
N/A
EIN:
N/A
DUNS:
607812414
Number of Employees:
28
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $69,988.00 1
STTR Phase I $139,955.00 1

Award List:

N/A

Award Year / Program / Phase:
2000 / STTR / Phase I
Award Amount:
$139,955.00
Agency:
HHS
Principal Investigator:
Alfred Stratcher, Principal Investigator
Research Institution:
State University of New York
RI Contact:
N/A
Abstract:
N/a

Chemical Casualty Care: Hydrogel Nanoparticle Aggregates as Wound Dressings Following Debridement of Cutaneuous Vesicant Injuries

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$69,988.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
John V. St. John, Senior Scientist
Abstract:
The proposed research will demonstrate the utility of hydrogel nanoparticle aggregates as bandages for post-debridement vesicant injuries. Dehydrated hydrogel nanoparticles in powder form are applied to the surface of a wound. The nanoparticles aggregate immediately and form a continuous hydrogel… More